Clinical Trial Update: A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of ipragliflozin in combination with insulin for type 2 diabetes; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• Suglat (ipragliflozin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED